16,117 iShares Biotechnology ETF $IBB Shares Bought by Kestra Advisory Services LLC

Kestra Advisory Services LLC grew its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 34.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 63,312 shares of the financial services provider’s stock after purchasing an additional 16,117 shares during the period. Kestra Advisory Services LLC owned approximately 0.12% of iShares Biotechnology ETF worth $13,329,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Bell Investment Advisors Inc bought a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $29,000. Pension & Wealth Management Advisors Inc. acquired a new position in iShares Biotechnology ETF during the second quarter worth $28,000. Provenance Wealth Advisors LLC acquired a new position in iShares Biotechnology ETF during the third quarter worth $35,000. Trust Co. of Vermont acquired a new position in iShares Biotechnology ETF during the second quarter worth $44,000. Finally, GKV Capital Management Co. Inc. acquired a new position in iShares Biotechnology ETF during the first quarter worth $49,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $213.63 on Monday. iShares Biotechnology ETF has a 52-week low of $154.98 and a 52-week high of $222.29. The business has a fifty day moving average of $208.46 and a two-hundred day moving average of $185.91. The stock has a market cap of $11.14 billion, a PE ratio of 26.08 and a beta of 0.72.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 18th. Investors of record on Tuesday, September 15th were given a dividend of $0.0112 per share. This is a decrease from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. The ex-dividend date was Tuesday, September 15th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.0%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.